Month: October 2021

A healthcare worker holds syringes with the Moderna and Pfizer vaccines against the coronavirus disease (COVID-19) at a vaccination centre, in El Paso, Texas, May 6, 2021. Jose Luis Gonzalez | Reuters Finland, Denmark and Sweden are limiting the use of Moderna‘s Covid-19 vaccine in young people over concerns around rare cardiovascular side effects. Finland’s
0 Comments
WASHINGTON — As Congress continues to struggle with debt ceiling and infrastructure issues, lawmakers continue to work on other bills, including those related to the health workforce. On Thursday, Sen. Tim Kaine (D-Va.) announced his co-sponsorship of a bill to increase the number of Medicare-funded graduate medical education (GME) slots by 14,000 over the next
0 Comments
I admit I’m a pumpkin junkie. As soon as I could get my pumpkin spice coffee (in August by the way), I was ordering it up. I full-on believe it should be embraced year-round—but for now, I guess we just have to continue to accept it for what it is, a FALL flavor. I asked
0 Comments
Mark Hoppus, vocalist and bassist for Blink-182, announced on social media that’s cancer-free, just six months after starting treatment. The singer announced his initial diagnosis on social media on June 23, 2021. In the announcement, he said he’d been in chemotherapy for three months because he had cancer. He said, “It sucks and I’m scared,
0 Comments
This episode, we’re joined by Sigourney Bell, a researcher at the University of Cambridge, whose work looks to find new treatments for supratentorial ependymoma, a rare children’s brain cancer. Outside of the lab, Sigourney is the co-founder of Black in Cancer, a global organisation that aims to strengthen the network between Black people in the
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A Texas man was sentenced to 15 months in prison on Monday for perpetrating a hoax related to COVID-19 last year. Christopher Charles Perez, 40, was found guilty on two counts of disseminating false information and hoaxes related to biological weapons,
0 Comments
Posted on October 5, 2021 by Admin At Atria, we admire sports icon and champion of equality Billie Jean King not only for her spectacular achievements in sports, but for how her indomitable spirit inspires us to create a more inclusive world. Her beliefs and life experience make her the perfect spokesperson for our Next Chapter series that explores how older adults are redefining aging. 
0 Comments
Do you enjoy drinking beer or wine? When consumed in moderation, studies show that enjoying such drinks every now and then can have positive effects on our bodies.  But as too much of anything is bad, make sure that your occasional “drink” doesn’t become a  habit and you just stick to a glass or two. Is Beer Bad for You? As drinking
0 Comments
The shift from medical school to residency has long pushed young doctors to their physical and mental limits. A new comprehensive report proposes a slate of reforms to make the path smoother and give doctors-in-training a stronger foundation to guide them through years of practice. The report, drafted by the Coalition for Physician Accountability’s Undergraduate
0 Comments
A technology developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) shows great promise for diagnosing Alzheimer’s disease before symptoms arise, potentially changing the course of research and treatment for this condition, which affects millions of people worldwide and is estimated to be the sixth leading cause of death in the United States. “This
0 Comments
Fresh from her Don Listwin Award presentation at The Early Detection of Cancer conference, we spoke to Professor Rebecca Fitzgerald about the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers… Whilst early detection research has yielded some incredible advances, there is still a long way to
0 Comments
Pairing the CDK4/6 inhibitor palbociclib (Ibrance) with fulvestrant as first-line treatment for advanced, hormone receptor-positive/HER2-negative breast cancer did not improve survival compared with standard treatment, the phase II PARSIFAL trial found. Over a median follow-up of 32 months, the primary endpoint of median investigator-assessed progression-free survival (PFS) was 27.9 months in the fulvestrant-palbociclib group versus
0 Comments
Although this story is accurate as of Monday, October 4, this is a very fast-moving story. For up to the minute developments, readers should also check here, and check their state health departments (list is here).   Confused about whether it’s time to head out for your COVID booster vaccine? You’re not alone. Over the past
0 Comments
Paediatric brain tumours are the leading cause of cancer-related death in children – we need new approaches to therapeutics. Here, Dr Lisa Ruff tells us why drug delivery is so important for the treatment of central nervous system tumours – and why hydrogels could be key to a breakthrough…     Among paediatric cancers, tumours developing
0 Comments
For people with hypertension and left ventricular hypertrophy (LVH), getting their blood pressure down as low as possible could help reduce their risk for cardiovascular disease (CVD) events, new research suggests. In a nationwide cohort study of Korean adults with LVH who were followed for more than 11 years, patients with a systolic blood pressure
0 Comments
Most vaccines are given with hypodermic needle injections. But shots aren’t necessarily the most efficient or effective way to deliver a vaccine. Scientists have been experimenting with microneedle patches to painlessly deliver a vaccine into the outermost layer of the skin with dozens of extremely tiny needles coated in the vaccine solution. Now, researchers have
0 Comments
It’s remarkable that the reputation of the National Institutes of Health has remained mostly intact through the covid-19 pandemic, even as other federal science agencies, including the Food and Drug Administration and Centers for Disease Control and Prevention, have come under partisan fire. That is in no small part due to NIH’s soft-spoken but politically
0 Comments